Walleye Trading LLC Arcus Biosciences, Inc. Put Options Transaction History

Walleye Trading LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	SELL	$13.43 - $19.63 $319,634 - $467,194	-23,800 Reduced 43.91%	30,400 $580,000
Q3 2023 Nov 14, 2023	SELL	$17.62 - $23.54 $444,024 - $593,208	-25,200 Reduced 31.74%	54,200 $972,000
Q2 2023 Aug 14, 2023	BUY	$16.97 - $22.03 $1.19 Million - $1.55 Million	70,400 Added 782.22%	79,400 $1.61 Million
Q1 2023 May 15, 2023	BUY	$15.96 - $23.15 $143,640 - $208,350	9,000 New	9,000 $164,000
Q3 2021 Nov 15, 2021	SELL	$26.93 - $37.68 $45,781 - $64,056	-1,700 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$22.75 - $35.77 $38,675 - $60,809	1,700 New	1,700 $47,000

200

51.5M

236K

141K

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.01B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.